Showing results (191-200 of 646) with videos related to
Sort By:
Pageof 65
Clinical Lymphoma & Myeloma|April 14, 2009
Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemiaMary L McMaster, Sigurdur Y Kristinsson, Ingemar Turesson, et al.Expert Review of Molecular Diagnostics|July 13, 2011
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical managementSigurdur Y Kristinsson, Alex R Minter, Neha Korde, et al.Haematologica|April 19, 2012
Thrombosis is associated with inferior survival in multiple myelomaSigurdur Y Kristinsson, Ruth M Pfeiffer, Magnus Björkholm, et al.Leukemia & Lymphoma|June 5, 2014
The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphomaHuei-Ting Tsai, Ruth M Pfeiffer, Joan Warren, et al.Cancer Immunology, Immunotherapy : CII|January 22, 2011
The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor modelTamar Tadmor, Yu Zhang, Hyun-Mi Cho, et al.Leukemia & Lymphoma|July 24, 2019
Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivorsEstherina Trachtenberg, Ronit Gurion, Tatiana Mashiach, et al.Leukemia & Lymphoma|April 29, 2009
The late adverse events of rituximab therapy--rare but there!Ron Ram, Isaac Ben-Bassat, Ofer Shpilberg, et al.JAMA Oncology|December 13, 2019
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A ReviewFrancesco Maura, Niccolò Bolli, Even H Rustad, et al.Blood|February 8, 2012
Second malignancies after multiple myeloma: from 1960s to 2010sAnish Thomas, Sham Mailankody, Neha Korde, et al.Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.Pageof 65